Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Canntab Therapeutics Limited (C:PILL)

Business Focus: Alternative Medicine

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

INK Ultra Money Free

Insider Filings

Latest 10 SEDI filings for PILL within the last 6 months
See all filings within the past 6 months

Company News

Jun 03, 2021 07:34 ET
Canntab Announces the Early Exercise of $1,259,250 Warrants
TORONTO, June 3, 2021 /CNW/ - Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to announce the receipt of C$1,259,250 in gross proceeds from the early exercise of  1,679,000 warrants into common shares (the "Warrants"). The Warrants were issued in the final week of May and each Warrant was exercised into 1 common share in the capital of the Company at $0.75. The Warrants were set to expire on late February or early March of 2
Read full article
May 25, 2021 09:49 ET
Canntab Mourns the Loss of Co-Founder
TORONTO, May 25, 2021 /CNW/ - Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), a leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, announces, with very heavy hearts, the passing of Jeffrey Ward Renwick, the Company's Co-Founder, Director and President.  After a long and difficult 15 month battle, Jeff succumbed to his lung cancer at the young age of 54 years. 
Read full article
See more news stories

Valuation Ratios

Price to Sales - TTM
Price to Book - most recent quarter
Price to Cash Flow per share - TTM
Price to Free Cash Flow per share - TTM
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Aug 31, 20211,280-23,902
Aug 15, 202125,18221,502
Jul 31, 20213,680-6,347
See Short Report

Business Summary

Sector:  Healthcare Industry:  Pharmaceuticals

Canntab Therapeutics Ltd, formerly Telferscot Resources Inc, is a Canada-based company engaged in alternatywe medicine sector. The Company is dedicated to the research and development of oral dosage therapeutic formulations of cannabis and a range of oral dosage products that treat different ailments by delivering a uniform dosage of medicinal cannabis extract. The Company developed bi-layered tablets that offer an immediate dosage and therefore immediate release of active ingredients, combined with its patent pending extended release formulations. Its Gel Capsules offer doctors and patients a uniform amount of THC/CBD oil extract, in a quick dissolving gel capsule. The Companys flash melt tablets are designed to dissolve immediately when placed under the tongue. They deliver an dosage to the patient, offering instant relief.

See business summary



Search (past week) for $PILL.CA

  • No tweets found